Skip to main content
Premium Trial:

Request an Annual Quote

No Mention of a Consolation Prize for Navigenics

This should quash any hopes you had that the 23andMe hype was dying down. Time magazine named the company's genome scan service as the 2008 Invention of the Year, crediting the firm with "pioneering retail genomics."

While Genetic Genealogist Blaine Bettinger congratulates 23andMe on the award, Larry Moran at Sandwalk takes issue with it. He contends that the technology has been around for years, so it really can't be considered an "invention"; he also charges that "there are serious ethical concerns about genetic testing that have not been resolved."

 

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.